We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
Cap. Flow
-$892M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
3.4 quarters
Top 10 Avg Time Held
2.1 quarters
Top 20 Avg Time Held
2.5 quarters

Top Buys

Rank Stock Value
1
NUS icon
Nu Skin
NUS
+$123M
2
DAN icon
Dana Inc
DAN
+$61.6M
3
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
+$55.3M
4
CVEO icon
Civeo
CVEO
+$37.3M
5
PLUS icon
ePlus
PLUS
+$30M

Sector Composition

Rank Sector Weight
1 Industrials 24.45%
2 Technology 18.1%
3 Consumer Discretionary 14.79%
4 Financials 9.92%
5 Materials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SEIC icon
76
SEI Investments
SEIC
$12.6B
$107M 0.32%
3,253,147
+83,675
+3% +$2.69M
2013 Q2
4 quarters
CCMP
77
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$104M 0.31%
2,321,875
-135,890
-6% -$5.88M
2013 Q2
4 quarters
CATO icon
78
Cato Corp
CATO
$48.2M
$102M 0.3%
3,314,408
-87,461
-3% -$2.54M
2013 Q2
4 quarters
AB icon
79
AllianceBernstein
AB
$3.21B
$100M 0.3%
3,882,070
-100,000
-3% -$2.5M
2013 Q2
4 quarters
FSTR icon
80
Foster
FSTR
$368M
$99.8M 0.3%
1,843,858
-6,828
-0.4% -$339K
2013 Q2
4 quarters
COLM icon
81
Columbia Sportswear
COLM
$2.89B
$97.8M 0.29%
2,367,252
-138,800
-6% -$5.79M
2013 Q2
4 quarters
BIO icon
82
Bio-Rad Laboratories Class A
BIO
$9.67B
$97.3M 0.29%
812,845
-60,025
-7% -$7.33M
2013 Q2
4 quarters
MANT
83
DELISTED
Mantech International Corp
MANT
$94.9M 0.28%
3,214,388
-308,426
-9% -$9.1M
2013 Q2
4 quarters
TDW icon
84
Tidewater
TDW
$4.25B
$93.8M 0.28%
51,793
-71
-0.1% -$118K
2013 Q2
4 quarters
BID
85
DELISTED
Sotheby's
BID
$92.4M 0.28%
2,200,367
+168,073
+8% +$6.84M
2013 Q2
4 quarters
UVV icon
86
Universal Corp
UVV
$1.04B
$92.2M 0.27%
1,665,564
+143,900
+9% +$7.84M
2013 Q2
4 quarters
MAN icon
87
ManpowerGroup
MAN
$2.4B
$90.4M 0.27%
1,065,812
+33,710
+3% +$2.74M
2013 Q2
4 quarters
DBD icon
88
DELISTED
Diebold Nixdorf Incorporated
DBD
$90.4M 0.27%
2,249,350
+217,450
+11% +$8.34M
2013 Q2
4 quarters
IRF
89
DELISTED
INTL RECTIFIER CORP
IRF
$89.8M 0.27%
3,219,205
+25,100
+0.8% +$673K
2013 Q2
4 quarters
GNTX icon
90
Gentex
GNTX
$4.41B
$89.5M 0.27%
6,154,016
+1,647,918
+37% +$24.1M
2013 Q2
4 quarters
MZTI icon
91
The Marzetti Company
MZTI
$2.75B
$87.9M 0.26%
923,300
-88,633
-9% -$8.2M
2013 Q2
4 quarters
GIII icon
92
G-III Apparel Group
GIII
$1.17B
$87.8M 0.26%
2,151,080
-72,682
-3% -$2.74M
2013 Q2
4 quarters
FN icon
93
Fabrinet
FN
$16.5B
$87.1M 0.26%
4,229,841
+575,656
+16% +$11.7M
2013 Q2
4 quarters
POOL icon
94
Pool Corp
POOL
$5.78B
$87M 0.26%
1,538,600
-200,000
-12% -$11.7M
2013 Q2
4 quarters
SCSC icon
95
Scansource
SCSC
$1.22B
$86.2M 0.26%
2,263,000
+473,600
+26% +$18.1M
2013 Q4
2 quarters
OIS icon
96
Oil States International
OIS
$499M
$86M 0.26%
1,341,291
-1,014,739
-43% -$59.7M
2013 Q2
4 quarters
PRE icon
97
DELISTED
PARTNERRE LTD
PRE
$85M 0.25%
778,072
-78,800
-9% -$8.32M
2013 Q2
4 quarters
KWR icon
98
Quaker Houghton
KWR
$2.7B
$84.1M 0.25%
1,095,705
+23,879
+2% +$1.81M
2013 Q2
4 quarters
AWH icon
99
DELISTED
Allied World Assurance Co Hld Lt
AWH
$84.1M 0.25%
2,211,350
-186,100
-8% -$6.78M
2013 Q2
4 quarters
CSL icon
100
Carlisle Companies
CSL
$12.7B
$83.9M 0.25%
968,050
-11,250
-1% -$935K
2013 Q2
4 quarters

Similar funds

Royce & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
  • Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
  • Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
  • Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
  • Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
  • Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.

Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.